142 related articles for article (PubMed ID: 14764768)
21. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
[TBL] [Abstract][Full Text] [Related]
22. Cardiac effect of thyrotoxicosis in acromegaly.
Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
[TBL] [Abstract][Full Text] [Related]
23. Intervertebral disc lesions in diffuse idiopathic skeletal hyperostosis (DISH).
di Girolamo C; Pappone N; Rengo C; Miniero E; Crisci C; Olivieri I
Clin Exp Rheumatol; 2001; 19(3):310-2. PubMed ID: 11407085
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of thoracic diffuse idiopathic skeletal hyperostosis (DISH) in Japanese: Results of chest CT-based cross-sectional study.
Mori K; Kasahara T; Mimura T; Nishizawa K; Nakamura A; Imai S
J Orthop Sci; 2017 Jan; 22(1):38-42. PubMed ID: 27697426
[TBL] [Abstract][Full Text] [Related]
25. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
26. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study.
Kiss C; Szilágyi M; Paksy A; Poór G
Rheumatology (Oxford); 2002 Jan; 41(1):27-30. PubMed ID: 11792876
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence and risk factors in diffuse idiopathic skeletal hyperostosis in a population sample in Hungary].
Kiss C; Szilágyi M; Mituszova M; Poór G
Orv Hetil; 1997 Jun; 138(25):1619-23. PubMed ID: 9265142
[TBL] [Abstract][Full Text] [Related]
29. Association between monoclonal gammopathy of undetermined significance (MGUS) and diffuse idiopathic skeletal hyperostosis (DISH).
Scutellari PN; Antinolfi G
Radiol Med; 2004 Sep; 108(3):172-9. PubMed ID: 15343131
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular consequences of early-onset growth hormone excess.
Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
[TBL] [Abstract][Full Text] [Related]
31. Energy metabolism and substrate oxidation in acromegaly.
O'Sullivan AJ; Kelly JJ; Hoffman DM; Baxter RC; Ho KK
J Clin Endocrinol Metab; 1995 Feb; 80(2):486-91. PubMed ID: 7852509
[TBL] [Abstract][Full Text] [Related]
32. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
33. Ossified ligamentum flavum causing spinal cord compression in a patient with acromegaly.
Schmidt RF; Goldstein IM; Liu JK
J Clin Neurosci; 2013 Nov; 20(11):1599-603. PubMed ID: 23706185
[TBL] [Abstract][Full Text] [Related]
34. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
[TBL] [Abstract][Full Text] [Related]
35. Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography.
Cannavo S; Almoto B; Cavalli G; Squadrito S; Romanello G; Vigo MT; Fiumara F; Benvenga S; Trimarchi F
J Clin Endocrinol Metab; 2006 Oct; 91(10):3766-72. PubMed ID: 16835284
[TBL] [Abstract][Full Text] [Related]
36. [Type AO/ASIF B3 fractures of the thoracic and lumbar spine].
Matějka J; Skála-Rosenbaum J; Krbec M; Zeman J; Matějka T; Zeman P
Acta Chir Orthop Traumatol Cech; 2013; 80(5):335-40. PubMed ID: 25105674
[TBL] [Abstract][Full Text] [Related]
37. Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases.
Zincarelli C; Iervolino S; Di Minno MN; Miniero E; Rengo C; Di Gioia L; Vitale D; Nicolino A; Furgi G; Pappone N
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1765-9. PubMed ID: 22623449
[TBL] [Abstract][Full Text] [Related]
38. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
39. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study.
Colao A; Pivonello R; Grasso LF; Auriemma RS; Galdiero M; Savastano S; Lombardi G
Eur J Endocrinol; 2011 Nov; 165(5):713-21. PubMed ID: 21868601
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
